BIOMAT Database Logo BIOMAT Database Logo

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. 1988

I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Rorer Biotechnology, Inc., Rockville, Maryland 20850.

Epidermal growth factor (EGF) receptor was affinity labeled with 125I-labeled EGF, using bifunctional covalent cross-linking agents. The affinity-labeled receptor was isolated and cleaved with CNBr to yield a single-labeled fragment, which was unequivocally identified by site-specific antibodies and other methods to encompass residues 294 to 543 of the EGF receptor. On the basis of amino acid sequence conservation, the extracellular portion of EGF receptor can be divided into four domains. The labeled CNBr fragment contains the entire sequence which is flanked by the two cysteine-rich domains of extracellular portion of the EGF receptor denoted as domain III. On the basis of these and other results, we propose that domain III contributes most of the interactions that define ligand-binding specificity of the EGF receptor.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000345 Affinity Labels Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. Affinity Labeling Reagents,Labeling Reagents, Affinity,Labels, Affinity,Reagents, Affinity Labeling

Related Publications

I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Affinity labeling of a cell surface receptor for epidermal growth factor.
January 1978, Progress in clinical and biological research,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region.
March 1984, Proceedings of the National Academy of Sciences of the United States of America,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
November 1982, Proceedings of the National Academy of Sciences of the United States of America,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Localization by photoaffinity labeling of natriuretic peptide receptor-A binding domain.
October 1996, Biochemistry,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
October 1994, European journal of biochemistry,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
January 1993, The Journal of biological chemistry,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.
November 1987, Proceedings of the National Academy of Sciences of the United States of America,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.
June 2002, Journal of biomolecular structure & dynamics,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
July 1997, Journal of biochemistry,
I Lax, and W H Burgess, and F Bellot, and A Ullrich, and J Schlessinger, and D Givol
EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.
November 1991, The Journal of biological chemistry,
Copied contents to your clipboard!